Allan G F, Sui Z
Reproductive Therapeutics, Johnson & Johnson Pharmaceutical Research and Development, 1000 US Route 202 South P.O. Box 300, Raritan, New Jersey 08869, USA.
Mini Rev Med Chem. 2005 Aug;5(8):701-8. doi: 10.2174/1389557054553794.
The nuclear receptor for progesterone is a target for contraception and for several therapeutic indications. Progestin agonists and antagonists in clinical use mimic the steroidal backbone of the cognate ligand, progesterone. Thus, they have significant cross-reactivity with other steroid receptors. Recently, non-steroidal progesterone receptor ligands have begun to appear in the literature. This review will describe the current status of research into these promising new chemical entities.
孕酮核受体是避孕及多种治疗适应症的作用靶点。临床使用的孕激素激动剂和拮抗剂模拟了同源配体孕酮的甾体骨架。因此,它们与其他甾体受体具有显著的交叉反应性。最近,非甾体孕酮受体配体已开始出现在文献中。本综述将描述这些有前景的新化学实体的研究现状。